Rubin-Bejerano, Ifat,Reznik, Gabriel Oscar,Dostalova, Zuzana,Sansal-Castellano, Isabelle
申请号：
AU2016209337
公开号：
AU2016209337A1
申请日:
2016.01.20
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention includes, among other things, β-1,6-glucan linked to an antibody directed to a cell present in a tumor microenvironment. T regulatory cells can be one type of cell present in the tumor microenvironment. In particular embodiments, the antibody is directed to a surface feature of a T regulatory cell, MDSC, or other immune cell. In certain embodiments, the antibody is directed to T regulatory cells, MDSCs, or other immune cells present in a tumor microenvironment. Compositions including β-1,6-glucan linked to an antibody directed to a T regulatory cell, MDSC, or other immune cell may be useful, e.g., in the treatment of a tumor or cancer in a subject in need thereof. Accordingly, the present invention provides, among other things, methods and compositions for treatment of a tumor or cancer.
